GHK-Cu

What Is GHK-Cu?

GHK-Cu is the copper(II) complex of the human tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys, abbreviated GHK). The free GHK peptide was originally isolated from human plasma and is also detectable in saliva and urine.

It exhibits high affinity for divalent copper, and the resulting GHK-Cu complex is the form most commonly studied in published research literature on skin biology, wound repair, and gene-expression modulation.

In the GHK-Cu complex, the Cu²⁺ ion is coordinated through nitrogen and oxygen donor atoms supplied by the glycine N-terminal amine, the histidine imidazole, and the peptide backbone, forming a stable but exchange-capable coordination structure in aqueous systems.

In published research literature, GHK-Cu is examined in extracellular matrix biology, fibroblast research, DNA repair gene expression, and cellular antioxidant defense pathways.

GHK-Cu in Plain Language

A non-technical overview of what GHK-Cu is, what researchers have studied it for, what early evidence suggests, and what cannot be claimed about it. For research and educational purposes only.

At a glance

GHK-Cu is a tiny copper-carrying peptide the body naturally produces, but in smaller amounts as we age. In published research, scientists study it for its role in supporting healthy skin, wound healing, collagen production, and hair-follicle activity.

Independent studies on the molecule itself (not on this exact product) have explored its effects on both wound recovery and hair shedding in clinical settings. The compound sold here is a research chemical, not a cosmetic or therapeutic product.

What it is

GHK-Cu is the copper(II) complex of a small natural human peptide called GHK, which is just three amino acids long: glycine, histidine, and lysine (Gly-His-Lys). The free GHK peptide was originally isolated from human blood plasma and is also detectable in saliva and urine.

GHK binds copper ions tightly, and the resulting GHK-Cu complex is the form most often studied in published research on skin biology, wound repair, and cellular signaling.

GHK-Cu is supplied as a lyophilized blue-violet powder, the color characteristic of copper complexes. Researchers commonly study it in laboratory contexts related to connective-tissue (collagen) biology, wound-healing models, gene-expression effects, and antioxidant signaling.

Research areas being investigated

• Collagen and connective-tissue research: Studied in fibroblast cell cultures for effects on collagen and glycosaminoglycan production, and on the cross-linking enzymes lysyl oxidase and lysyl hydroxylase that need copper as a cofactor.
• Wound-healing research: Examined in animal models of skin, connective-tissue, and bone repair, including diabetic and ischemic wound models.
• Skin-biology research: Investigated for effects on extracellular matrix proteins (decorin, dermatan sulfate, chondroitin sulfate) and matrix-metalloproteinase (MMP / TIMP) balance in dermal cell culture.
• Gene-expression and DNA-repair research: Connectivity Map analyses report broad upregulation of DNA-repair-related genes in cell culture systems exposed to GHK.
• Antioxidant and inflammation research: Studied for effects on superoxide dismutase (SOD) activity and on inflammatory pathways such as NFκB and p38 MAPK in cell models.
• Copper-delivery research: Examined as a tool to deliver copper to cells and copper-dependent enzymes in laboratory assays.

What the research suggests so far

Animal / preclinical findings. Most published GHK-Cu evidence comes from rodent and other animal models. In these studies, researchers have reported observations consistent with faster wound closure in skin models, including diabetic and ischemic wound models, alongside reductions in inflammatory cytokines (TNF-α) and matrix metalloproteinases (MMP-2, MMP-9).

GHK-Cu has also been examined in connective tissue, bone, liver, and stomach-lining repair models. These findings do not, on their own, demonstrate the same effects in humans.

Cell / lab findings. In cell-culture experiments, GHK-Cu has been described as stimulating collagen and glycosaminoglycan synthesis in dermal fibroblast cultures, restoring function in irradiated fibroblasts, and modulating gene-expression programs related to DNA repair and oxidative stress defense. Mechanistic work also points to blockade of NFκB p65 nuclear translocation and inhibition of p38 MAPK phosphorylation.

These findings inform hypotheses about how GHK-Cu might act in tissue, but they remain preclinical.

Human findings. Human evidence for GHK-Cu is limited to small cosmetic-formulation studies (commonly involving topical creams containing GHK-Cu) reporting changes in skin parameters such as wrinkle depth and skin density. There are no large, published Phase III randomized controlled trials demonstrating efficacy for any medical condition.

GHK-Cu is not approved by the FDA, EMA, or other major regulators as a drug for any use.

Limitations of the evidence. The GHK-Cu literature is dominated by cell-culture and small-animal work, with much of it traceable to a small number of research programs. Standardized human dosing studies, large efficacy trials, and independent multi-laboratory replication are lacking.

Reviewers in the peer-reviewed literature have specifically called out the need for more rigorous human studies before any therapeutic conclusions can be drawn.

Research relevance

GHK-Cu is most often discussed in research involving extracellular matrix biology, collagen and glycosaminoglycan synthesis, wound-healing models, copper-dependent enzyme cofactor research, DNA-repair gene expression, and inflammatory and antioxidant signaling. Most published findings are preclinical, so it should not be presented as a proven treatment for any condition.

Its scientific interest lies in its potential use as a research tool for studying skin biology, tissue repair, and copper-dependent cell biology in the laboratory.

What cannot be claimed about GHK-Cu

• It cannot be claimed to treat, cure, heal, or repair any human or animal condition.
• It cannot be claimed to reverse aging, regrow hair, or eliminate wrinkles.
• It cannot be claimed to heal wounds in humans or veterinary patients.
• It cannot be claimed to repair DNA damage in humans.
• It cannot be claimed to be safe or effective for human or veterinary use.
• It cannot be claimed to be approved by the FDA or any other regulatory authority as a drug.

Summary

GHK-Cu is the copper(II) complex of the natural human tripeptide glycyl-L-histidyl-L-lysine (GHK). It is studied in laboratory and animal research related to extracellular matrix biology, collagen and glycosaminoglycan synthesis, wound-healing models, DNA-repair gene expression, and inflammatory and antioxidant signaling pathways. Published evidence comes mainly from cell-culture and rodent experiments; human evidence is limited to small cosmetic-formulation studies.

GHK-Cu is not approved by the FDA or any other regulatory authority as a drug and is sold here strictly as a research-use-only chemical for laboratory investigation. It is not intended for human consumption, medical use, or veterinary use.

Short version

GHK-Cu is the copper-bound form of a small natural human tripeptide (glycyl-histidyl-lysine). It is most often studied in cell and animal research on collagen, wound healing, gene expression, and antioxidant signaling. Human evidence is limited and it is not approved for any medical use. Sold for research and laboratory use only.

Source notes

• Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed, 2008, review article. (PubMed PMID: 18534104.)
• Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int, 2015, review article. (PMC4508379.)
• Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in light of the new gene data. Int J Mol Sci, 2018, review article. (PMC6073405.)
• Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev, 2012, review article. (PMC3359723.)
• Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A ‘metastasis-prone’ signature for early-stage mismatch-repair-proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis, 2010, cited as the gene-expression dataset on which subsequent GHK Connectivity Map analysis was based.
• Tripeptides in Wound Healing and Skin Regeneration, comprehensive review (Int J Med Sci, 2025), including coverage of GHK-Cu in extracellular matrix and skin biology research.

Source types: entries 1, 2, 3, 4, 6 are review articles; entry 5 is a primary cell-biology dataset referenced in subsequent GHK gene-expression analyses.

SEO meta description

GHK-Cu, the copper complex of the human tripeptide GHK, is studied in preclinical research on extracellular matrix biology, wound healing, and gene expression. Research-use only.

Reminder. BioChain USA sells GHK-Cu strictly as a research-use-only chemical for qualified laboratory and educational use. It is not intended for human consumption, medical treatment, veterinary treatment, diagnosis, prevention, or cure of disease.

Certificate of Analysis (COA)

• COA provided where available for the specific batch shipped.
• The batch COA is the authoritative reference for analytical methods, purity data, and lot-specific testing for that shipment.
• COA information is batch-specific and is not interchangeable between lots.

Frequently Asked Questions